Longeveron receives Japanese patent for potency assay methods to assess human mesenchymal stem cells
Longeveron receives Japanese patent for potency assay methods to assess human mesenchymal stem cells: Miami Saturday, January 31, 2026, 13:00 Hrs [IST] Longeveron Inc, a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results